CONTRA ACHILLION PHARM's ticker is and the CUSIP is 004CVR031. A total of 3 filers reported holding CONTRA ACHILLION PHARM in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,509 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q2 2023 | $2,509 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q1 2023 | $2,509 | -13.1% | 6,273 | 0.0% | 0.00% | – |
| Q4 2022 | $2,886 | -3.8% | 6,273 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 6,273 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 6,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LOGAN CAPITAL MANAGEMENT INC | 20,000 | $0 | 0.00% |
| Pacer Advisors, Inc. | 6,273 | $3,000 | 0.00% |
| AMALGAMATED BANK | 12,580 | $0 | 0.00% |